YAP suppresses human T-cell leukemia virus type 1 transcription
YAP suppresses human T-cell leukemia virus type 1 transcription
复制标题
DOI:
10.1002/jmv.29065
复制
发表时间:
2023-09-01
影响因子:
12.7
通讯作者:
Zhao,Tiejun
中科院分区:
文献类型:
--
作者:
Li,Hengbo;Zou,Feng;Zhao,Tiejun
Human T‐cell leukemia virus type 1 (HTLV‐1) is the first human retrovirus to be identified as the causative agent of human diseases including adult T‐cell leukemia/lymphoma (ATL) and HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP). 1, 2 After a long latent period of several decades, approximately 3%–5% of HTLV‐1‐infected individuals develop ATL. 1 High HTLV‐1 proviral load in cells seems to be the major risk for the development of ATL. 3 Understanding the mechanism by which HTLV‐1 regulates viral transcription might provide valuable insight into the strategies for prevention of HTLV‐1 associated diseases. The HTLV‐1 proviral genome is approximately 9000 bp long and flanked by long terminal repeat (LTR) sequences at both ends. 4 In addition to essential retroviral structural proteins, such as gag, pol, and env, the characteristic of HTLV‐1 proviral genome is the presence of a unique pX region between env and the 3'LTR. 4 The pX region encodes several viral regulatory proteins including Tax, Rex, p12, p13, p30, and HTLV‐1 bZIP factor (HBZ). 1, 5 Among them, Tax and HBZ play critical roles in the development of ATL by regulating